Tag: Metabolic Diseases

Shared Brain Signature Identified Across Five Major Psychedelics

April 7, 2026

Shared Brain Signature Identified Across Five Major Psychedelics

Target Product Profiles for Alzheimer’s Disease Prevention Therapies

April 3, 2026

Target Product Profiles for Alzheimer’s Disease Prevention Therapies

Author Correction: Real-World Utility of Tumor Whole-Genome Sequencing

April 3, 2026

Author Correction: Real-World Utility of Tumor Whole-Genome Sequencing

Nature Medicine: Advancing Health Information Access

April 2, 2026

Nature Medicine: Advancing Health Information Access

Semaglutide Reduces Cardiovascular Events by 20% in High-Risk Patients | SELECT Trial

April 2, 2026

Semaglutide Reduces Cardiovascular Events by 20% in High-Risk Patients | SELECT Trial

Cross-Sector Collaboration for Global Nutrition | Nature Medicine

April 2, 2026

Cross-Sector Collaboration for Global Nutrition | Nature Medicine

Semaglutide & Alzheimer’s: Phase 3 Trial Results & New Insights (2026)

April 2, 2026

Semaglutide & Alzheimer’s: Phase 3 Trial Results & New Insights (2026)

TB Pipeline: Promising Drugs & Vaccines Fuel Fight Against Global Killer

April 2, 2026

TB Pipeline: Promising Drugs & Vaccines Fuel Fight Against Global Killer

NATRON Study: Design of a Phase 3 Trial of Benralizumab for Hypereosinophilic Syndrome (HES)

March 31, 2026

NATRON Study: Design of a Phase 3 Trial of Benralizumab for Hypereosinophilic Syndrome (HES)

NR4A1 Drives Immune Evasion and Resistance to Therapy in Pancreatic Cancer

March 31, 2026

NR4A1 Drives Immune Evasion and Resistance to Therapy in Pancreatic Cancer

Web Analytics Made Easy - Statcounter